This metabolite features a PDE selectivity profile just like sildenafil and an in vitro potency for PDE5 somewhere around 50% on the father or mother drug. Plasma concentrations of the metabolite are roughly 40% of Those people viewed for sildenafil, so that the metabolite accounts for approximately 20% of sildenafil's pharmacologic outcomes.) The